Forecasting the Demand for Companion Diagnostics (CDx) for CLDN18.2...

добавлена новая статья Другое

2026-04-01 07:05:11 - Перевод -

Forecasting the Demand for Companion Diagnostics (CDx) for CLDN18.2 and HER2: Evaluating 2026 Gains in Targeted Therapy Selection (2025–2032)

The global healthcare community is placing an unprecedented emphasis on early intervention for gastrointestinal malignancies. The Gastric Cancer Diagnostics Market is at a pivotal juncture, transitioning from traditional symptomatic testing to advanced, biomarker-driven screening protocols. As gastric cancer remains one of the leading causes of cancer-related mortality worldwide, the...

0 Комментарии 0 Поделились 748 Просмотры 0 предпросмотр